If you invest in the stock market, you must know the Cupid share price target for 2026, 2027, 2028, 2029, and 2030. Here, you will get detailed information regarding all your queries, such as its fundamentals, shareholdings, financial performance, future predictions, and more.
About Cupid Ltd.
Cupid is a well-known company in the healthcare and personal wellness sector, primarily focused on manufacturing male and female condoms. The company operates in India and exports to several international markets, supporting its global business growth. Cupid benefits from growing health awareness, population control programs, and the increasing demand for affordable contraceptive products. Its business model is supported by government tenders and consistent export orders. With a focus on quality, safety standards, and cost-effective production, Cupid attracts long-term investors looking for healthcare stocks, FMCG-related stocks, and high-growth small-cap opportunities in the Indian stock market.
Fundamental Analysis of Cupid
| Market Cap. | ₹10,472.90 Cr. |
| ROE | 18.27% |
| ROCE | 17.05% |
| P/E | 169.56 |
| P/B | 27.47 |
| Dividend Yield | 0% |
| Book Value | ₹14.20 |
| Face Value | ₹1 |
| 52-Week High | ₹527.40 |
| 52-Week Low | ₹50 |
Cupid Share Price Target 2026
After analysing past price trends and market performance, it is estimated that the Cupid stock price could reach a minimum of ₹400 and potentially achieve a maximum target of ₹600 in the year 2026.
| Year 2026 | Target Price |
|---|---|
| Minimum Price | ₹400 |
| Maximum Price | ₹600 |
Cupid Share Price Target 2027
After analysing past price trends and market performance, it is estimated that the Cupid stock price could reach a minimum of ₹60 and potentially achieve a maximum target of ₹900 in the year 2027.
| Year 2027 | Target Price |
|---|---|
| Minimum Price | ₹600 |
| Maximum Price | ₹900 |
Cupid Share Price Target 2028
After analysing past price trends and market performance, it is estimated that the Cupid stock price could reach a minimum of ₹1000 and potentially achieve a maximum target of ₹1500 in the year 2028.
| Year 2028 | Target Price |
|---|---|
| Minimum Price | ₹1000 |
| Maximum Price | ₹1500 |
Cupid Share Price Target 2029
After analysing past price trends and market performance, it is estimated that the Cupid stock price could reach a minimum of ₹1500 and potentially achieve a maximum target of ₹2000 in the year 2029.
| Year 2029 | Target Price |
|---|---|
| Minimum Price | ₹1500 |
| Maximum Price | ₹2000 |
Cupid Share Price Target 2030
After analysing past price trends and market performance, it is estimated that the Cupid stock price could reach a minimum of ₹2300 and potentially achieve a maximum target of ₹3000 in the year 2030.
| Year 2030 | Target Price |
|---|---|
| Minimum Price | ₹2300 |
| Maximum Price | ₹3000 |
Shareholding Pattern of Cupid
| Retail & Others | 51.52% |
| Promoters | 45.55% |
| Foreign Institutions | 2.58% |
| Other Domestic Institutions | 0.18% |
| Mutual Funds | 0.16% |
Should You Invest in Cupid Stock?
| Year | Target Price (₹) |
|---|---|
| 2026 | 400–600 |
| 2027 | 600–900 |
| 2028 | 1000–1500 |
| 2029 | 1500–2000 |
| 2030 | 2300–3000 |
Whether you should invest or not depends on many factors. Let us know the risks and opportunities to invest in Cupid stock.
Opportunities
- Strong demand for healthcare and contraceptive products supports the business’s stable growth and long-term stock potential.
- Export-focused revenue allows the company to benefit from global market expansion and foreign income.
- Government health programs generate regular bulk orders and revenue visibility.
- Low competition in female condom manufacturing provides pricing and volume advantages.
- Increasing awareness about sexual health improves future sales and brand value.
Risks
- Over-reliance on government tenders could impact revenue stability.
- Export business faces currency risks and global policy changes.
- Limited product range may slow growth compared to more diverse healthcare companies.
- The small-cap stock nature may lead to greater price volatility.
- Issues related to regulatory and quality compliance could impact production and market confidence.
Key Competitors of Cupid
Key competitors or peer companies of Cupid Limited are Reckitt Benckiser, HLL Lifecare, Mankind Pharma, Church and Dwight, Okamoto Industries, Karex Berhad, Mayer Laboratories, TTK Healthcare, Fuji Latex, and Ansell.
Disclaimer: All the information provided in this article is for educational purposes only. DateUpdateGo always advises seeking guidance from a certified financial advisor before making any investment-related decisions.
